NovoCure (NVCR) Interest Coverage Ratio Growth (3y) (2017 - 2026)
NovoCure (NVCR) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 43.57% |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.62% |
| Dec 31, 2025 | -35.20% |
| Sep 30, 2025 | 25.71% |
| Jun 30, 2025 | -13.84% |
| Mar 31, 2025 | -206.44% |
| Dec 31, 2024 | -88.28% |
| Sep 30, 2024 | -33.18% |
| Jun 30, 2024 | -10.01% |
| Mar 31, 2024 | -8,446.30% |
| Dec 31, 2023 | -26.27% |
| Mar 31, 2023 | -321.09% |
| Dec 31, 2022 | 548.93% |
| Sep 30, 2022 | -424.97% |
| Jun 30, 2022 | -431.91% |
| Mar 31, 2022 | -11.27% |
| Dec 31, 2021 | -44.22% |
| Sep 30, 2021 | -41.65% |
| Jun 30, 2021 | -82.45% |
| Mar 31, 2021 | 76.65% |
| Dec 31, 2020 | 801.93% |